Primary Peritoneal Carcinoma Clinical Trials in Shanghai, Shanghai Municipality
2 recruitingShanghai, Shanghai Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab764 enrolled66 locationsNCT05579366
Recruiting
Phase 2
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)
Primary Peritoneal CarcinomaFallopian Tube CancerOvarian Cancer Recurrent
Shanghai Gynecologic Oncology Group167 enrolled5 locationsNCT03983226